Literature DB >> 8394458

Gibbon ape leukemia virus and the amphotropic murine leukemia virus 4070A exhibit an unusual interference pattern on E36 Chinese hamster cells.

M A Eglitis1, M V Eiden, C A Wilson.   

Abstract

The gibbon ape leukemia virus (GaLV), the amphotropic mouse leukemia virus (A-MLV) 4070A, and the xenotropic mouse leukemia virus (X-MLV) exhibit wide but not identical species host ranges. However, most Chinese hamster cells resist infection by all three viruses. We have now determined that the Chinese hamster cell line E36 differs from other Chinese hamster cell lines in that it is susceptible to infection by wild-type GaLV, A-MLV, and X-MLV. Surprisingly, analysis of the interference pattern of GaLV and A-MLV in E36 cells indicated that GaLV and A-MLV interfere in a nonreciprocal fashion. E36 cells productively infected with GaLV were resistant to superinfection by both GaLV and amphotropically packaged recombinant retroviral vectors. In contrast, E36 cells infected with A-MLV were resistant to superinfection with an amphotropic vector but could still be infected by a GaLV vector. These results imply the existence of a receptor on E36 cells that interacts with both GaLV and A-MLV.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8394458      PMCID: PMC237949     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Established kidney cell lines of normal adult bovine and ovine origin.

Authors:  S H MADIN; N B DARBY
Journal:  Proc Soc Exp Biol Med       Date:  1958-07

2.  Cultivation in vitro of cells derived from a human osteosarcoma.

Authors:  R M McAllister; M B Gardner; A E Greene; C Bradt; W W Nichols; B H Landing
Journal:  Cancer       Date:  1971-02       Impact factor: 6.860

3.  8-Azaguanine resistance in mammalian cells. I. Hypoxanthine-guanine phosphoribosyltransferase.

Authors:  F D Gillin; D J Roufa; A L Beaudet; C T Caskey
Journal:  Genetics       Date:  1972-10       Impact factor: 4.562

4.  Naturally occurring murine leukemia viruses in wild mice: characterization of a new "amphotropic" class.

Authors:  J W Hartley; W P Rowe
Journal:  J Virol       Date:  1976-07       Impact factor: 5.103

5.  Factors affecting retroviral vector function and structural integrity.

Authors:  J R McLachlin; N Mittereder; M B Daucher; M Kadan; M A Eglitis
Journal:  Virology       Date:  1993-07       Impact factor: 3.616

6.  Tunicamycin treatment of CHO cells abrogates multiple blocks to retrovirus infection, one of which is due to a secreted inhibitor.

Authors:  D G Miller; A D Miller
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

7.  The requirements for viral entry differ from those for virally induced syncytium formation in NIH 3T3/DTras cells exposed to Moloney murine leukemia virus.

Authors:  C A Wilson; J W Marsh; M V Eiden
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

8.  Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells.

Authors:  J L Jainchill; S A Aaronson; G J Todaro
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

9.  Detection of receptor-specific murine leukemia virus binding to cells by immunofluorescence analysis.

Authors:  M J Kadan; S Sturm; W F Anderson; M A Eglitis
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Genetics of somatic mammalian cells. III. Long-term cultivation of euploid cells from human and animal subjects.

Authors:  T T PUCK; S J CIECIURA; A ROBINSON
Journal:  J Exp Med       Date:  1958-12-01       Impact factor: 14.307

View more
  19 in total

1.  Host range and receptor binding properties of vectors bearing feline leukemia virus subgroup B envelopes can be modulated by envelope sequences outside of the receptor binding domain.

Authors:  Peggy Ho Faix; Steven A Feldman; Julie Overbaugh; Maribeth V Eiden
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Mutational analysis of the proposed gibbon ape leukemia virus binding site in Pit1 suggests that other regions are important for infection.

Authors:  G J Chaudry; M V Eiden
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Dissection of gammaretroviral receptor function by using type III phosphate transporters as models.

Authors:  Karen B Farrell; Maribeth V Eiden
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Subcellular redistribution of Pit-2 P(i) transporter/amphotropic leukemia virus (A-MuLV) receptor in A-MuLV-infected NIH 3T3 fibroblasts: involvement in superinfection interference.

Authors:  Z Jobbagy; S Garfield; L Baptiste; M V Eiden; W B Anderson
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  Characterization of hortulanus endogenous murine leukemia virus, an endogenous provirus that encodes an infectious murine leukemia virus of a novel subgroup.

Authors:  Christopher H Tipper; Craig E Bencsics; John M Coffin
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 6.  Transmission, Evolution, and Endogenization: Lessons Learned from Recent Retroviral Invasions.

Authors:  Alex D Greenwood; Yasuko Ishida; Sean P O'Brien; Alfred L Roca; Maribeth V Eiden
Journal:  Microbiol Mol Biol Rev       Date:  2017-12-13       Impact factor: 11.056

7.  Properties of a unique form of the murine amphotropic leukemia virus receptor expressed on hamster cells.

Authors:  C A Wilson; K B Farrell; M V Eiden
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  A family of retroviruses that utilize related phosphate transporters for cell entry.

Authors:  D G Miller; A D Miller
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

Review 9.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03

10.  Genetic and biochemical analyses of receptor and cofactor determinants for T-cell-tropic feline leukemia virus infection.

Authors:  Adam S Lauring; Heather H Cheng; Maribeth V Eiden; Julie Overbaugh
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.